xanthenes has been researched along with Depressive Disorder in 22 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 16 (72.73) | 18.2507 |
2000's | 1 (4.55) | 29.6817 |
2010's | 5 (22.73) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pałucha-Poniewiera, A; Pilc, A; Podkowa, K | 1 |
Ago, Y; Hasebe, S; Hashimoto, H; Matsuda, T; Nishiyama, S; Oka, S; Onaka, Y; Takuma, K | 1 |
Basta-Kaim, A; Budziszewska, B; Głombik, K; Holst, B; Młyniec, K; Nowak, G; Siwek, A; Skrzeszewski, J; Ślusarczyk, J; Trojan, E | 1 |
Lenda, T; Pałucha-Poniewiera, A; Pilc, A; Podkowa, A; Podkowa, K; Sałat, K | 1 |
Chaki, S; Fukumoto, K; Iijima, M; Koike, H | 1 |
Girardi, P; Giusti, P; Gruber, SH; Iacovelli, L; Mathé, AA; Matrisciano, F; Nicoletti, F; Panaccione, I; Tatarelli, R; Zusso, M | 1 |
De Smet, PA; Nolen, WA | 1 |
Linde, K; Melchart, D; Mulrow, CD; Pauls, A; Ramirez, G; Weidenhammer, W | 1 |
Kasper, S | 1 |
Brockow, K; Golsch, S; Rakoski, J; Ring, J; Vocks, E | 1 |
Rampes, H | 1 |
Volz, HP | 1 |
Arnoldt, KH; Hübner, WD; Vorbach, EU | 1 |
Czekalla, J; Gastpar, M; Hübner, WD; Jäger, D | 1 |
Adler, M | 1 |
Nierenberg, A | 1 |
Myers, J | 1 |
Miller, AL | 1 |
Baghai, T; Kieser, M; Laakmann, G; Schüle, C | 1 |
Cott, JM; Fugh-Berman, A | 1 |
4 review(s) available for xanthenes and Depressive Disorder
Article | Year |
---|---|
St John's wort for depression--an overview and meta-analysis of randomised clinical trials.
Topics: Antidepressive Agents; Depressive Disorder; Dose-Response Relationship, Drug; Drug Combinations; Humans; Hypericum; Perylene; Plant Extracts; Plants, Medicinal; Quercetin; Randomized Controlled Trials as Topic; Treatment Outcome; Xanthenes | 1996 |
Controlled clinical trials of hypericum extracts in depressed patients--an overview.
Topics: Antidepressive Agents; Controlled Clinical Trials as Topic; Depressive Disorder; Humans; Hypericum; Perylene; Plant Extracts; Plants, Medicinal; Quercetin; Xanthenes | 1997 |
Can an herb really help depression?
Topics: Antidepressive Agents; Depressive Disorder; Humans; Hypericum; Nonprescription Drugs; Perylene; Plants, Medicinal; Quercetin; Xanthenes | 1998 |
St. John's Wort (Hypericum perforatum): clinical effects on depression and other conditions.
Topics: Depression; Depressive Disorder; Humans; Hypericum; Perylene; Plant Extracts; Plants, Medicinal; Quercetin; Xanthenes | 1998 |
3 trial(s) available for xanthenes and Depressive Disorder
Article | Year |
---|---|
Efficacy and tolerability of St. John's wort extract LI 160 versus imipramine in patients with severe depressive episodes according to ICD-10.
Topics: Adult; Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Female; Humans; Hypericum; Imipramine; Male; Middle Aged; Perylene; Plants, Medicinal; Psychiatric Status Rating Scales; Quercetin; Xanthenes | 1997 |
The effect of hypericum extract on cardiac conduction as seen in the electrocardiogram compared to that of imipramine.
Topics: Adult; Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Electrocardiography; Female; Heart Conduction System; Humans; Hypericum; Imipramine; Male; Middle Aged; Perylene; Plants, Medicinal; Psychiatric Status Rating Scales; Quercetin; Xanthenes | 1997 |
St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy.
Topics: Antidepressive Agents; Bridged Bicyclo Compounds; Depressive Disorder; Double-Blind Method; Female; Humans; Hypericum; Male; Middle Aged; Perylene; Phloroglucinol; Plant Extracts; Plants, Medicinal; Quercetin; Terpenes; Xanthenes | 1998 |
15 other study(ies) available for xanthenes and Depressive Disorder
Article | Year |
---|---|
Role of AMPA receptor stimulation and TrkB signaling in the antidepressant-like effect of ketamine co-administered with a group II mGlu receptor antagonist, LY341495, in the forced swim test in rats.
Topics: Amino Acids; Animals; Antidepressive Agents; Azepines; Benzamides; Depression; Depressive Disorder; Excitatory Amino Acid Antagonists; Ketamine; Male; Prefrontal Cortex; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptor, trkB; Receptors, AMPA; Receptors, Metabotropic Glutamate; Signal Transduction; Xanthenes | 2019 |
The Female Encounter Test: A Novel Method for Evaluating Reward-Seeking Behavior or Motivation in Mice.
Topics: Amino Acids; Animals; Antidepressive Agents, Second-Generation; Castration; Choice Behavior; Corticosterone; Depressive Disorder; Disease Models, Animal; Equipment Design; Estrous Cycle; Excitatory Amino Acid Antagonists; Female; Fluvoxamine; Lipopolysaccharides; Male; Mice; Motivation; Nucleus Accumbens; Psychological Tests; Reward; Social Behavior; Social Isolation; Xanthenes | 2015 |
Immune malfunction in the GPR39 zinc receptor of knockout mice: Its relationship to depressive disorder.
Topics: Animals; Cell Proliferation; Cell Survival; Concanavalin A; Cytokines; Depressive Disorder; Disease Models, Animal; Female; Gene Expression Regulation; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitogens; Motor Activity; Organ Size; Oxazines; Receptors, G-Protein-Coupled; Spleen; Swimming; Thymocytes; Xanthenes | 2016 |
Antidepressant-like effects of scopolamine in mice are enhanced by the group II mGlu receptor antagonist LY341495.
Topics: Amino Acids; Animals; Antidepressive Agents; Depressive Disorder; Excitatory Amino Acid Antagonists; Male; Maze Learning; Mice; Mice, Inbred C57BL; Motor Activity; Prefrontal Cortex; Quinoxalines; Receptors, AMPA; Receptors, Metabotropic Glutamate; Scopolamine; Serotonin; Xanthenes | 2016 |
Role of BDNF/TrkB signaling in antidepressant-like effects of a group II metabotropic glutamate receptor antagonist in animal models of depression.
Topics: Amino Acids; Animals; Antidepressive Agents; Behavior, Animal; Brain-Derived Neurotrophic Factor; Depressive Disorder; Disease Models, Animal; Excitatory Amino Acid Antagonists; Exploratory Behavior; Hindlimb Suspension; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Receptor, trkB; Receptors, Metabotropic Glutamate; Signal Transduction; Xanthenes | 2013 |
Group-II metabotropic glutamate receptor ligands as adjunctive drugs in the treatment of depression: a new strategy to shorten the latency of antidepressant medication?
Topics: Adjuvants, Pharmaceutic; Amino Acids; Animals; Antidepressive Agents, Tricyclic; Bridged Bicyclo Compounds, Heterocyclic; Depressive Disorder; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Excitatory Amino Acid Agents; Hippocampus; Imipramine; In Vitro Techniques; Mice; Neurons; Rats; Rats, Inbred Strains; Receptor Cross-Talk; Receptors, Metabotropic Glutamate; Time Factors; Xanthenes | 2007 |
St John's wort as an antidepressant.
Topics: Antidepressive Agents; Depressive Disorder; Humans; Hypericum; Perylene; Plant Extracts; Plants, Medicinal; Quercetin; Xanthenes | 1996 |
[A plant extract with proven antidepressive effect].
Topics: Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder; Humans; Hypericum; Perylene; Plants, Medicinal; Quercetin; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Xanthenes | 1997 |
[Antidepressive effectiveness and good tolerance].
Topics: Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder; Humans; Hypericum; Perylene; Plants, Medicinal; Quercetin; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Xanthenes | 1997 |
[Hypericum perforatum in psychiatric practice].
Topics: Antidepressive Agents; Depressive Disorder; Dose-Response Relationship, Drug; Humans; Hypericum; Perylene; Plants, Medicinal; Quercetin; Selective Serotonin Reuptake Inhibitors; Xanthenes | 1997 |
[Reversible increase in photosensitivity to UV-B caused by St. John's wort extract].
Topics: Antidepressive Agents; Depressive Disorder; Dermatitis, Photoallergic; Drug Eruptions; Female; Humans; Hypericum; Middle Aged; Patch Tests; Perylene; Plants, Medicinal; Quercetin; Ultraviolet Rays; Xanthenes | 1997 |
Hypericum, an over the counter antidepressant?
Topics: Antidepressive Agents; Depressive Disorder; Drug Interactions; Humans; Hypericum; Nonprescription Drugs; Perylene; Plants, Medicinal; Quercetin; Treatment Outcome; Xanthenes | 1997 |
[Prediction: onset of improved mood after 2 weeks. Hypericum therapy in intermediate class depression. Interview by Dr. rer. nat. Till Uwe Keil].
Topics: Antidepressive Agents; Depressive Disorder; Humans; Hypericum; Perylene; Plants, Medicinal; Quercetin; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Xanthenes | 1997 |
Should you take St. John's Wort?
Topics: Depression; Depressive Disorder; Humans; Hypericum; Perylene; Phytotherapy; Plant Extracts; Plants, Medicinal; Quercetin; Xanthenes | 1998 |
Is St. John's wort (Hypericum perforatum) an effective antidepressant?
Topics: Animals; Anthracenes; Antidepressive Agents; Depressive Disorder; Humans; Hypericum; Nonprescription Drugs; Perylene; Phytotherapy; Plant Extracts; Plants, Medicinal; Protein Kinase C; Quercetin; Rats; Xanthenes | 1998 |